| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8959051 | Biological Psychiatry | 2018 | 45 Pages |
Abstract
Sodium benzoate adjuvant therapy improved symptomatology of patients with clozapine-resistant schizophrenia. Further studies are warranted to elucidate the optimal dose and treatment duration as well as the mechanisms of sodium benzoate for clozapine-resistant schizophrenia.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Chieh-Hsin Lin, Ching-Hua Lin, Yue-Cune Chang, Yu-Jhen Huang, Po-Wei Chen, Hui-Ting Yang, Hsien-Yuan Lane,